RNS Number : 1348O
Haydale Graphene Industries PLC
30 January 2023
 

 

For immediate release

30 January 2023

 

 

Haydale Graphene Industries plc

 

('Haydale')

 

Notice of Interim Results

 

Haydale, (AIM: HAYD), the global technology solutions company, will announce its unaudited interim results for the six months ended 31 December 2022 on Wednesday, 1 March 2023. The Board looks forward to updating shareholders with further details at that time. 

 

 

For further information:

Haydale Graphene Industries plc

Keith Broadbent, CEO                                                                                              Tel: +44 (0) 1269 842946

Mark Chapman, CFO

 

finnCap (Nominated Adviser & Broker)

Julian Blunt / Edward Whiley, Corporate Finance                                               Tel: +44 (0) 20 7220 0500

Andrew Burdis, ECM

 

Notes to Editors

 

Haydale is a global technologies group and service provider that facilitates the integration of graphene and other nanomaterials into the next generation of industrial materials and commercial technologies.  With expertise in graphene, other nanomaterials and Silicon Carbide, Haydale is able to deliver improvements in electrical, thermal and mechanical properties,  Haydale has been granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from five sites in the UK, USA and the Far East.  For more information please visit: www.haydale.com or Twitter: @haydalegraphene

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFDLFLXFLXBBX